OP0163 Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Vascular and Myocardial Abnormalities on Cardiac MRI
BackgroundCardiac studies of patients with rheumatoid arthritis (RA) have demonstrated abnormalities in left ventricular (LV) remodelling that is associated with development of heart failure and cardiovascular (CV) morbidity and mortality1,2. No studies to date have evaluated for changes in myocardi...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.130-131 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 131 |
---|---|
container_issue | Suppl 2 |
container_start_page | 130 |
container_title | Annals of the rheumatic diseases |
container_volume | 74 |
creator | Erhayiem, B. McDiarmid, A. Swoboda, P. Kidambi, A. Ripley, D. Musa, T.A. Dobson, L.E. Garg, P. Horton, S.C. Dumitru, R.B. Andrews, J. Greenwood, J. Emery, P. Plein, S. Buch, M.H. |
description | BackgroundCardiac studies of patients with rheumatoid arthritis (RA) have demonstrated abnormalities in left ventricular (LV) remodelling that is associated with development of heart failure and cardiovascular (CV) morbidity and mortality1,2. No studies to date have evaluated for changes in myocardial and vascular function in treatment-naïve early RA (ERA).ObjectivesTo evaluate whether patients with newly diagnosed, treatment-naïve ERA demonstrate myocardial and vascular changes on cardiac MRI (CMR) compared with matched controls.MethodsSixty-six ERA patients fulfilling ACR/EULAR classification criteria and with no CVD history underwent 3.0T CMR (Philips Achieva TX) at a cardiology-CMR unit. All patients had symptoms for less than 1 year, were DMARD treatment-naïve and with minimum disease activity score (DAS28) ≥3.2. Thirty healthy controls (HC) were matched by age, sex and blood pressure.Standard balanced steady state free precession cine images were acquired and LV dimensions calculated. For aortic distensibility, multi-phase SSFP cine images (50 phases) were acquired in a plane transverse to the ascending aorta at the level of the pulmonary artery bifurcation. Aortic contours were drawn by manual planimetry of the endovascular–blood pool interface at the times of minimal and maximal distension. Additional parameters measured include strain analysis and extracellular volume (results awaited). Body surface area (BSA) index values are presented.ResultsPatients in ERA and HC groups were similar mean (SD) age [49.4 (13.08) and 46.7 (11.4) respectively, p=0.33] and systolic BP [122 (23) and 126 (16) respectively, p=0.18]. Mean (SD) BSA was lower in the ERA group vs HC [(1.83 (0.22) vs 1.9 (0.21) respectively, p=0.09]. In the ERA group, median (IQR) ESR, CRP and mean (SD) DAS28 were 39.5 (28.7)mm/hr, 18.9 (27.1)mg/L and 5.65 (1.6) respectively. 54 (82%) and 48 (73%) patients were ACPA and RF positive respectively.Table 1 details CMR parameters. Aortic distensibility was significantly reduced in ERA patients compared to HC (median ± IQR, 3.19±2.16 10-3mmHg-1 versus 4.4±2.1 10-3mmHg-1, p=0.001). Other measures of arterial stiffness including aortic stiffness index, compliance and strain showed similar significant differences. Left ventricular and right ventricular end-systolic and end-diastolic volumes were all significantly lower in the ERA vs HC. A trend for lower LVmass index in the ERA group was observed and seemed to be associated with seropositivity (see |
doi_str_mv | 10.1136/annrheumdis-2015-eular.5279 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1901802457</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4322506951</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1857-4d923bc37621e5820e3df637b8ff82dac9df46c1deb34ecaf1be6eafd582542a3</originalsourceid><addsrcrecordid>eNqVkEtOwzAQhi0EEuVxB0tsCdhx4iRiVZVXJUorBGytSTxRUyUO2A5SV7DhPByCm3ASEsqCLStrPN8_v_QRcsTZCedCnoIxdoldoysXhIzHAXY12JM4TLItMuKRTPtvybbJiDEmgiiTyS7Zc27Vjyzl6Yi8zheMS_H19n5vEXyDxge38Pnxgsf0Amy9pndDAfi20nRs_dJWvnJ0Ab7qUUfPsWmN8xY80kdwxdBPwWg6W7cFWF1BTce5aW0DdZ9ER1tDJz-Lgs7upgdkp4Ta4eHvu08eLi_uJ9fBzfxqOhnfBDlP4ySIdBaKvBCJDDnGachQ6FKKJE_LMg01FJkuI1lwjbmIsICS5ygRSt2zcRSC2CdHm7tPtn3u0Hm1ajtr-krFM8ZTFkZx0lNnG6qwrXMWS_VkqwbsWnGmBuPqj3E1GFc_xtVgvE_LTTpvVv8KfgOoXJBa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901802457</pqid></control><display><type>article</type><title>OP0163 Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Vascular and Myocardial Abnormalities on Cardiac MRI</title><source>BMJ Journals - NESLi2</source><creator>Erhayiem, B. ; McDiarmid, A. ; Swoboda, P. ; Kidambi, A. ; Ripley, D. ; Musa, T.A. ; Dobson, L.E. ; Garg, P. ; Horton, S.C. ; Dumitru, R.B. ; Andrews, J. ; Greenwood, J. ; Emery, P. ; Plein, S. ; Buch, M.H.</creator><creatorcontrib>Erhayiem, B. ; McDiarmid, A. ; Swoboda, P. ; Kidambi, A. ; Ripley, D. ; Musa, T.A. ; Dobson, L.E. ; Garg, P. ; Horton, S.C. ; Dumitru, R.B. ; Andrews, J. ; Greenwood, J. ; Emery, P. ; Plein, S. ; Buch, M.H.</creatorcontrib><description>BackgroundCardiac studies of patients with rheumatoid arthritis (RA) have demonstrated abnormalities in left ventricular (LV) remodelling that is associated with development of heart failure and cardiovascular (CV) morbidity and mortality1,2. No studies to date have evaluated for changes in myocardial and vascular function in treatment-naïve early RA (ERA).ObjectivesTo evaluate whether patients with newly diagnosed, treatment-naïve ERA demonstrate myocardial and vascular changes on cardiac MRI (CMR) compared with matched controls.MethodsSixty-six ERA patients fulfilling ACR/EULAR classification criteria and with no CVD history underwent 3.0T CMR (Philips Achieva TX) at a cardiology-CMR unit. All patients had symptoms for less than 1 year, were DMARD treatment-naïve and with minimum disease activity score (DAS28) ≥3.2. Thirty healthy controls (HC) were matched by age, sex and blood pressure.Standard balanced steady state free precession cine images were acquired and LV dimensions calculated. For aortic distensibility, multi-phase SSFP cine images (50 phases) were acquired in a plane transverse to the ascending aorta at the level of the pulmonary artery bifurcation. Aortic contours were drawn by manual planimetry of the endovascular–blood pool interface at the times of minimal and maximal distension. Additional parameters measured include strain analysis and extracellular volume (results awaited). Body surface area (BSA) index values are presented.ResultsPatients in ERA and HC groups were similar mean (SD) age [49.4 (13.08) and 46.7 (11.4) respectively, p=0.33] and systolic BP [122 (23) and 126 (16) respectively, p=0.18]. Mean (SD) BSA was lower in the ERA group vs HC [(1.83 (0.22) vs 1.9 (0.21) respectively, p=0.09]. In the ERA group, median (IQR) ESR, CRP and mean (SD) DAS28 were 39.5 (28.7)mm/hr, 18.9 (27.1)mg/L and 5.65 (1.6) respectively. 54 (82%) and 48 (73%) patients were ACPA and RF positive respectively.Table 1 details CMR parameters. Aortic distensibility was significantly reduced in ERA patients compared to HC (median ± IQR, 3.19±2.16 10-3mmHg-1 versus 4.4±2.1 10-3mmHg-1, p=0.001). Other measures of arterial stiffness including aortic stiffness index, compliance and strain showed similar significant differences. Left ventricular and right ventricular end-systolic and end-diastolic volumes were all significantly lower in the ERA vs HC. A trend for lower LVmass index in the ERA group was observed and seemed to be associated with seropositivity (see table 2). Evidence for overt inflammation/fibrosis was seen in 4 patients with focal non-ischaemic patterns of LGE.ConclusionsThis first CMR study in treatment-naive ERA demonstrates abnormalities at the earliest stage of RA. Reduced vascular function, ventricular volumes, and trend change in LV geometry suggest an early cardiomyopathy. This might imply higher risk for CV morbidity and mortality at time of diagnosis. Further investigation will clarify the natural history, clinical implications and the scope to modify outcome with effective RA therapy.ReferencesGiles JT, et al. Arthritis Rheum 2010 2. Myasoedova E, et al. Arthritis Rheum 2013Disclosure of InterestNone declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2015-eular.5279</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><ispartof>Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.130-131</ispartof><rights>2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2015 (c) 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b1857-4d923bc37621e5820e3df637b8ff82dac9df46c1deb34ecaf1be6eafd582542a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/74/Suppl_2/130.3.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/74/Suppl_2/130.3.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3183,23550,27901,27902,77569,77600</link.rule.ids></links><search><creatorcontrib>Erhayiem, B.</creatorcontrib><creatorcontrib>McDiarmid, A.</creatorcontrib><creatorcontrib>Swoboda, P.</creatorcontrib><creatorcontrib>Kidambi, A.</creatorcontrib><creatorcontrib>Ripley, D.</creatorcontrib><creatorcontrib>Musa, T.A.</creatorcontrib><creatorcontrib>Dobson, L.E.</creatorcontrib><creatorcontrib>Garg, P.</creatorcontrib><creatorcontrib>Horton, S.C.</creatorcontrib><creatorcontrib>Dumitru, R.B.</creatorcontrib><creatorcontrib>Andrews, J.</creatorcontrib><creatorcontrib>Greenwood, J.</creatorcontrib><creatorcontrib>Emery, P.</creatorcontrib><creatorcontrib>Plein, S.</creatorcontrib><creatorcontrib>Buch, M.H.</creatorcontrib><title>OP0163 Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Vascular and Myocardial Abnormalities on Cardiac MRI</title><title>Annals of the rheumatic diseases</title><description>BackgroundCardiac studies of patients with rheumatoid arthritis (RA) have demonstrated abnormalities in left ventricular (LV) remodelling that is associated with development of heart failure and cardiovascular (CV) morbidity and mortality1,2. No studies to date have evaluated for changes in myocardial and vascular function in treatment-naïve early RA (ERA).ObjectivesTo evaluate whether patients with newly diagnosed, treatment-naïve ERA demonstrate myocardial and vascular changes on cardiac MRI (CMR) compared with matched controls.MethodsSixty-six ERA patients fulfilling ACR/EULAR classification criteria and with no CVD history underwent 3.0T CMR (Philips Achieva TX) at a cardiology-CMR unit. All patients had symptoms for less than 1 year, were DMARD treatment-naïve and with minimum disease activity score (DAS28) ≥3.2. Thirty healthy controls (HC) were matched by age, sex and blood pressure.Standard balanced steady state free precession cine images were acquired and LV dimensions calculated. For aortic distensibility, multi-phase SSFP cine images (50 phases) were acquired in a plane transverse to the ascending aorta at the level of the pulmonary artery bifurcation. Aortic contours were drawn by manual planimetry of the endovascular–blood pool interface at the times of minimal and maximal distension. Additional parameters measured include strain analysis and extracellular volume (results awaited). Body surface area (BSA) index values are presented.ResultsPatients in ERA and HC groups were similar mean (SD) age [49.4 (13.08) and 46.7 (11.4) respectively, p=0.33] and systolic BP [122 (23) and 126 (16) respectively, p=0.18]. Mean (SD) BSA was lower in the ERA group vs HC [(1.83 (0.22) vs 1.9 (0.21) respectively, p=0.09]. In the ERA group, median (IQR) ESR, CRP and mean (SD) DAS28 were 39.5 (28.7)mm/hr, 18.9 (27.1)mg/L and 5.65 (1.6) respectively. 54 (82%) and 48 (73%) patients were ACPA and RF positive respectively.Table 1 details CMR parameters. Aortic distensibility was significantly reduced in ERA patients compared to HC (median ± IQR, 3.19±2.16 10-3mmHg-1 versus 4.4±2.1 10-3mmHg-1, p=0.001). Other measures of arterial stiffness including aortic stiffness index, compliance and strain showed similar significant differences. Left ventricular and right ventricular end-systolic and end-diastolic volumes were all significantly lower in the ERA vs HC. A trend for lower LVmass index in the ERA group was observed and seemed to be associated with seropositivity (see table 2). Evidence for overt inflammation/fibrosis was seen in 4 patients with focal non-ischaemic patterns of LGE.ConclusionsThis first CMR study in treatment-naive ERA demonstrates abnormalities at the earliest stage of RA. Reduced vascular function, ventricular volumes, and trend change in LV geometry suggest an early cardiomyopathy. This might imply higher risk for CV morbidity and mortality at time of diagnosis. Further investigation will clarify the natural history, clinical implications and the scope to modify outcome with effective RA therapy.ReferencesGiles JT, et al. Arthritis Rheum 2010 2. Myasoedova E, et al. Arthritis Rheum 2013Disclosure of InterestNone declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqVkEtOwzAQhi0EEuVxB0tsCdhx4iRiVZVXJUorBGytSTxRUyUO2A5SV7DhPByCm3ASEsqCLStrPN8_v_QRcsTZCedCnoIxdoldoysXhIzHAXY12JM4TLItMuKRTPtvybbJiDEmgiiTyS7Zc27Vjyzl6Yi8zheMS_H19n5vEXyDxge38Pnxgsf0Amy9pndDAfi20nRs_dJWvnJ0Ab7qUUfPsWmN8xY80kdwxdBPwWg6W7cFWF1BTce5aW0DdZ9ER1tDJz-Lgs7upgdkp4Ta4eHvu08eLi_uJ9fBzfxqOhnfBDlP4ySIdBaKvBCJDDnGachQ6FKKJE_LMg01FJkuI1lwjbmIsICS5ygRSt2zcRSC2CdHm7tPtn3u0Hm1ajtr-krFM8ZTFkZx0lNnG6qwrXMWS_VkqwbsWnGmBuPqj3E1GFc_xtVgvE_LTTpvVv8KfgOoXJBa</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Erhayiem, B.</creator><creator>McDiarmid, A.</creator><creator>Swoboda, P.</creator><creator>Kidambi, A.</creator><creator>Ripley, D.</creator><creator>Musa, T.A.</creator><creator>Dobson, L.E.</creator><creator>Garg, P.</creator><creator>Horton, S.C.</creator><creator>Dumitru, R.B.</creator><creator>Andrews, J.</creator><creator>Greenwood, J.</creator><creator>Emery, P.</creator><creator>Plein, S.</creator><creator>Buch, M.H.</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201506</creationdate><title>OP0163 Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Vascular and Myocardial Abnormalities on Cardiac MRI</title><author>Erhayiem, B. ; McDiarmid, A. ; Swoboda, P. ; Kidambi, A. ; Ripley, D. ; Musa, T.A. ; Dobson, L.E. ; Garg, P. ; Horton, S.C. ; Dumitru, R.B. ; Andrews, J. ; Greenwood, J. ; Emery, P. ; Plein, S. ; Buch, M.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1857-4d923bc37621e5820e3df637b8ff82dac9df46c1deb34ecaf1be6eafd582542a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erhayiem, B.</creatorcontrib><creatorcontrib>McDiarmid, A.</creatorcontrib><creatorcontrib>Swoboda, P.</creatorcontrib><creatorcontrib>Kidambi, A.</creatorcontrib><creatorcontrib>Ripley, D.</creatorcontrib><creatorcontrib>Musa, T.A.</creatorcontrib><creatorcontrib>Dobson, L.E.</creatorcontrib><creatorcontrib>Garg, P.</creatorcontrib><creatorcontrib>Horton, S.C.</creatorcontrib><creatorcontrib>Dumitru, R.B.</creatorcontrib><creatorcontrib>Andrews, J.</creatorcontrib><creatorcontrib>Greenwood, J.</creatorcontrib><creatorcontrib>Emery, P.</creatorcontrib><creatorcontrib>Plein, S.</creatorcontrib><creatorcontrib>Buch, M.H.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erhayiem, B.</au><au>McDiarmid, A.</au><au>Swoboda, P.</au><au>Kidambi, A.</au><au>Ripley, D.</au><au>Musa, T.A.</au><au>Dobson, L.E.</au><au>Garg, P.</au><au>Horton, S.C.</au><au>Dumitru, R.B.</au><au>Andrews, J.</au><au>Greenwood, J.</au><au>Emery, P.</au><au>Plein, S.</au><au>Buch, M.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OP0163 Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Vascular and Myocardial Abnormalities on Cardiac MRI</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2015-06</date><risdate>2015</risdate><volume>74</volume><issue>Suppl 2</issue><spage>130</spage><epage>131</epage><pages>130-131</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>BackgroundCardiac studies of patients with rheumatoid arthritis (RA) have demonstrated abnormalities in left ventricular (LV) remodelling that is associated with development of heart failure and cardiovascular (CV) morbidity and mortality1,2. No studies to date have evaluated for changes in myocardial and vascular function in treatment-naïve early RA (ERA).ObjectivesTo evaluate whether patients with newly diagnosed, treatment-naïve ERA demonstrate myocardial and vascular changes on cardiac MRI (CMR) compared with matched controls.MethodsSixty-six ERA patients fulfilling ACR/EULAR classification criteria and with no CVD history underwent 3.0T CMR (Philips Achieva TX) at a cardiology-CMR unit. All patients had symptoms for less than 1 year, were DMARD treatment-naïve and with minimum disease activity score (DAS28) ≥3.2. Thirty healthy controls (HC) were matched by age, sex and blood pressure.Standard balanced steady state free precession cine images were acquired and LV dimensions calculated. For aortic distensibility, multi-phase SSFP cine images (50 phases) were acquired in a plane transverse to the ascending aorta at the level of the pulmonary artery bifurcation. Aortic contours were drawn by manual planimetry of the endovascular–blood pool interface at the times of minimal and maximal distension. Additional parameters measured include strain analysis and extracellular volume (results awaited). Body surface area (BSA) index values are presented.ResultsPatients in ERA and HC groups were similar mean (SD) age [49.4 (13.08) and 46.7 (11.4) respectively, p=0.33] and systolic BP [122 (23) and 126 (16) respectively, p=0.18]. Mean (SD) BSA was lower in the ERA group vs HC [(1.83 (0.22) vs 1.9 (0.21) respectively, p=0.09]. In the ERA group, median (IQR) ESR, CRP and mean (SD) DAS28 were 39.5 (28.7)mm/hr, 18.9 (27.1)mg/L and 5.65 (1.6) respectively. 54 (82%) and 48 (73%) patients were ACPA and RF positive respectively.Table 1 details CMR parameters. Aortic distensibility was significantly reduced in ERA patients compared to HC (median ± IQR, 3.19±2.16 10-3mmHg-1 versus 4.4±2.1 10-3mmHg-1, p=0.001). Other measures of arterial stiffness including aortic stiffness index, compliance and strain showed similar significant differences. Left ventricular and right ventricular end-systolic and end-diastolic volumes were all significantly lower in the ERA vs HC. A trend for lower LVmass index in the ERA group was observed and seemed to be associated with seropositivity (see table 2). Evidence for overt inflammation/fibrosis was seen in 4 patients with focal non-ischaemic patterns of LGE.ConclusionsThis first CMR study in treatment-naive ERA demonstrates abnormalities at the earliest stage of RA. Reduced vascular function, ventricular volumes, and trend change in LV geometry suggest an early cardiomyopathy. This might imply higher risk for CV morbidity and mortality at time of diagnosis. Further investigation will clarify the natural history, clinical implications and the scope to modify outcome with effective RA therapy.ReferencesGiles JT, et al. Arthritis Rheum 2010 2. Myasoedova E, et al. Arthritis Rheum 2013Disclosure of InterestNone declared</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1136/annrheumdis-2015-eular.5279</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4967 |
ispartof | Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.130-131 |
issn | 0003-4967 1468-2060 |
language | eng |
recordid | cdi_proquest_journals_1901802457 |
source | BMJ Journals - NESLi2 |
title | OP0163 Treatment-Naïve, Early Rheumatoid Arthritis Patients Demonstrate Vascular and Myocardial Abnormalities on Cardiac MRI |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A39%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OP0163%E2%80%85Treatment-Na%C3%AFve,%20Early%20Rheumatoid%20Arthritis%20Patients%20Demonstrate%20Vascular%20and%20Myocardial%20Abnormalities%20on%20Cardiac%20MRI&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Erhayiem,%20B.&rft.date=2015-06&rft.volume=74&rft.issue=Suppl%202&rft.spage=130&rft.epage=131&rft.pages=130-131&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2015-eular.5279&rft_dat=%3Cproquest_cross%3E4322506951%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1901802457&rft_id=info:pmid/&rfr_iscdi=true |